Search

Your search keyword '"Kawaoka, Yoshihiro"' showing total 3,286 results

Search Constraints

Start Over You searched for: Author "Kawaoka, Yoshihiro" Remove constraint Author: "Kawaoka, Yoshihiro"
3,286 results on '"Kawaoka, Yoshihiro"'

Search Results

202. Characterization of the SARS-CoV-2 B.1.621 (Mu) variant

203. Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

207. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma

213. Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.

214. Continued Circulation of Highly Pathogenic H5 Influenza Viruses in Vietnamese Live Bird Markets in 2018–2021.

215. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.

217. Age-stratified seroprevalence of antibodies against SARS-CoV-2 in the pre- and post-vaccination era, February 2020–March 2022, Japan

218. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 clinical isolates

219. Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.

220. Parsing the role of NSP1 in SARS-CoV-2 infection

221. Generation of Transgenic Mosquitoes Harboring a Replication-Restricted Virus

222. Isolation of bat sarbecoviruses of SARS-CoV-2 clade, Japan

224. Gain-of-Function Experiments on H7N9

225. Transmission Studies Resume For Avian Flu

232. Robustness of the Ferret Model for Influenza Risk Assessment Studies:a Cross-Laboratory Exercise

233. Defining the risk of SARS-CoV-2 variants on immune protection

235. The Potential for Respiratory Droplet-Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host

240. Pause on Avian Flu Transmission Research

243. Multi-omics Characterization of Neutrophil Extracellular Trap Formation in Severe and Mild COVID-19 Infections

244. Immunological Correlates of Prevention of the Onset of Seasonal H3N2 Influenza

246. Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

247. Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals

248. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual

Catalog

Books, media, physical & digital resources